For: | Huang MJ, Yang SS, Lin MS, Huang CS. Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World J Gastroenterol 2005; 11(6): 797-802 [PMID: 15682470 DOI: 10.3748/wjg.v11.i6.797] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i6/797.htm |
Number | Citing Articles |
1 |
Yuji Ishii, Yuu Miyauchi, Hideyuki Yamada. Fifty Years of Cytochrome P450 Research. 2014; : 307 doi: 10.1007/978-4-431-54992-5_18
|
2 |
M Saeki, Y Saito, H Jinno, K Sai, S Ozawa, K Kurose, N Kaniwa, K Komamura, T Kotake, H Morishita, S Kamakura, M Kitakaze, H Tomoike, K Shirao, T Tamura, N Yamamoto, H Kunitoh, T Hamaguchi, T Yoshida, K Kubota, A Ohtsu, M Muto, H Minami, N Saijo, N Kamatani, J-i Sawada. Haplotype structures of the UGT1A gene complex in a Japanese population. The Pharmacogenomics Journal 2006; 6(1): 63 doi: 10.1038/sj.tpj.6500335
|
3 |
Pei-Hua Lu, Min-Bin Chen, Xiao-Yang Wu, Jin-Hua Gu, Yuan Liu, Rong-min Gu. Genetic Polymorphisms of UGT1A7 and Cancer Risk: Evidence From 21 Case–Control Studies. Cancer Investigation 2011; 29(10): 645 doi: 10.3109/07357907.2011.626477
|
4 |
Jai N. Patel. Cancer pharmacogenomics. Pharmacogenetics and Genomics 2015; 25(5): 223 doi: 10.1097/FPC.0000000000000134
|
5 |
Hironobu Minami, Kimie Sai, Mayumi Saeki, Yoshiro Saito, Shogo Ozawa, Kazuhiro Suzuki, Nahoko Kaniwa, Jun-ichi Sawada, Tetsuya Hamaguchi, Noboru Yamamoto, Kuniaki Shirao, Yasuhide Yamada, Hironobu Ohmatsu, Kaoru Kubota, Teruhiko Yoshida, Atsushi Ohtsu, Nagahiro Saijo. Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28. Pharmacogenetics and Genomics 2007; 17(7): 497 doi: 10.1097/FPC.0b013e328014341f
|
6 |
H‐C Teng, M‐J Huang, K‐S Tang, S‐S Yang, C‐S Tseng, C‐S Huang. Combined UGT1A1 and UGT1A7 variant alleles are associated with increased risk of Gilbert’s syndrome in Taiwanese adults. Clinical Genetics 2007; 72(4): 321 doi: 10.1111/j.1399-0004.2007.00873.x
|
7 |
Hiromichi Maeda, Shoichi Hazama, Abdiev Shavkat, Ken Okamoto, Koji Oba, Junichi Sakamoto, Kenichi Takahashi, Masaki Oka, Daisuke Nakamura, Ryouichi Tsunedomi, Naoko Okayama, Hideyuki Mishima, Michiya Kobayashi. Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations. Molecular Diagnosis & Therapy 2014; 18(3): 333 doi: 10.1007/s40291-014-0083-6
|
8 |
Chien-Sen Tseng, Kung-Sheng Tang, Hoi-Wan Lo, Chen-Guo Ker, Hsiu-Chen Teng, Ching-Shan Huang. UDP-Glucuronosyltransferase 1A7 Genetic Polymorphisms Are Associated with Hepatocellular Carcinoma Risk and Onset Age. The American Journal of Gastroenterology 2005; 100(8): 1758 doi: 10.1111/j.1572-0241.2005.41857.x
|
9 |
Choong-kun Lee, Hong Jae Chon, Woo Sun Kwon, Hyo-Jeong Ban, Sang Cheol Kim, Hyunwook Kim, Hei-Cheul Jeung, Jimyung Chung, Sun Young Rha. The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients. Genomics & Informatics 2022; 20(3): e29 doi: 10.5808/gi.22051
|
10 |
Shouji Shimoyama. Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events. World Journal of Gastrointestinal Surgery 2010; 2(1): 14-21 doi: 10.4240/wjgs.v2.i1.14
|
11 |
Yuji Ishii, Hiroki Koba, Kousuke Kinoshita, Toshiya Oizaki, Yuki Iwamoto, Shuso Takeda, Yuu Miyauchi, Yoshio Nishimura, Natsuki Egoshi, Futoshi Taura, Satoshi Morimoto, Shin’ichi Ikushiro, Kiyoshi Nagata, Yasushi Yamazoe, Peter I. Mackenzie, Hideyuki Yamada. Alteration of the Function of the UDP-Glucuronosyltransferase 1A Subfamily by Cytochrome P450 3A4: Different Susceptibility for UGT Isoforms and UGT1A1/7 Variants. Drug Metabolism and Disposition 2014; 42(2): 229 doi: 10.1124/dmd.113.054833
|
12 |
Janelle M. Hoskins, Howard L. McLeod. UGT1A and Irinotecan Toxicity: Keeping It in the Family. Journal of Clinical Oncology 2009; 27(15): 2419 doi: 10.1200/JCO.2008.20.9478
|
13 |
Ken-ichi Fujita, Yuichi Ando, Fumio Nagashima, Wataru Yamamoto, Hisashi Eodo, Kazuhiro Araki, Keiji Kodama, Toshimichi Miya, Masaru Narabayashi, Yasutsuna Sasaki. Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer. Cancer Chemotherapy and Pharmacology 2007; 60(4): 515 doi: 10.1007/s00280-006-0396-1
|
14 |
Ching-Shan Huang. Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese. Journal of Biomedical Science 2005; 12(3): 445 doi: 10.1007/s11373-005-3863-5
|
15 |
Kung-Sheng Tang, Chuan-Mo Lee, Hsiu-Chen Teng, May-Jen Huang, Ching-Shan Huang. UDP-glucuronosyltransferase 1A7 polymorphisms are associated with liver cirrhosis. Biochemical and Biophysical Research Communications 2008; 366(3): 643 doi: 10.1016/j.bbrc.2007.11.125
|
16 |
Shingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima. A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development. Drug Metabolism and Pharmacokinetics 2015; 30(1): 30 doi: 10.1016/j.dmpk.2014.12.001
|
17 |
Fei‐Liang Wong, May‐Kay Wang, Nem‐Yun Boo, N.H. Hamidah, B. Othaman Ainoon. Rapid detection of the UGT1A1 single nucleotide polymorphism G211A using real‐time PCR with Taqman minor groove binder probes. Journal of Clinical Laboratory Analysis 2007; 21(3): 167 doi: 10.1002/jcla.20177
|
18 |
Christoph Schulz, Stefan Boeck, Volker Heinemann, Hans-Joachim Stemmler. UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?. Anti-Cancer Drugs 2009; 20(10): 867 doi: 10.1097/CAD.0b013e328330c7d2
|
19 |
Marzia Del Re, Tiziana Latiano, Leonardo Fidilio, Giuliana Restante, Franco Morelli, Evaristo Maiello, Romano Danesi. Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment. EPMA Journal 2017; 8(1): 69 doi: 10.1007/s13167-017-0080-z
|
20 |
Jacqueline Ramírez, Mark J Ratain, Federico Innocenti. Uridine 5´-Diphospho-Glucuronosyltransferase Genetic Polymorphisms and Response to Cancer Chemotherapy. Future Oncology 2010; 6(4): 563 doi: 10.2217/fon.10.17
|